Azathioprine eyed for liver toxicity risk in rheumatoid arthritis patientsHospitalization for acute hepatotoxicity among rheumatoid arthritis patients appears to be related to previous liver disease as well as treatment with the immunosuppressant azathioprine, Canadian researchers reported here. Anti-TNF agents do not raise cancer risk in arthritis patientsFinding reassuring since class of drugs has mandated warning on labels about potential risk of cancer Clinical Notes: Orlistat safety questioned Risk of acute kidney injury increased within one year of starting the antiobesity drug orlistat, study finds. Vimovo: first NSAID–PPI combo now available in Canada AstraZeneca introducing first fixed-dose combination product containing a nonsteroidal anti-inflammatory drug and proton pump inhibitor. NHP Forum: Preventing and treating osteoporosis Exploring natural options for the treatment of osteoporosis. Early treatment improves outcomes in rheumatoid arthritis Methotrexate-prednisone combo achieves remission in nearly two-thirds of patients Rheumatoid arthritis biologics may provoke shingles outbreaks Researchers advise clinicians to be vigilant when prescribing anti-TNF therapy Vitamin D fails to relieve knee osteoarthritis pain Impotency drug cures Raynaud’s fingertip ulcers Vaccinations not linked to rheumatoid arthritis First Previous 16 17 18 19 20 Next Last
